GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Eli Lilly and Co LLY · USD

Health Care · Pharmaceuticals · US listing · 🇺🇸 United States

S&P 500

Compare

1,354.00

-0.79%

Close of 6 Nov 2026, in USD

Latest on Eli Lilly and Co

Our reporting

Next results

3 Feb 2027

Due on 3 Feb 2027. Analysts expect earnings of 11.20 a share on revenue of $24.58bn.

Past results

Reported against what analysts expected

29 Oct 20265 Aug 202630 Apr 20264 Feb 202630 Oct 20257 Aug 2025
Earnings per share7.488.388.557.547.026.31
Forecast5.716.406.976.915.695.60
Revenue$24.40bn$22.97bn$19.80bn$19.29bn$17.60bn$15.56bn
Forecast$22.58bn$20.82bn$17.82bn$17.94bn$16.05bn$14.70bn

Key events

  1. 16 Oct 19972-for-1 share split
  2. 21 Dec 19952-for-1 share split
  3. 1 May 19892-for-1 share split
  4. 9 Jul 1970Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.